⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Figure S1 from Treatment of prostate cancer with CD46 targeted ²²⁵Ac alpha particle radioimmunotherapy

Anil P. Bidkar Sinan Wang Kondapa Naidu Bobba Emily Chan Scott Bidlingmaier Emily A. Egusa Robin Peter Umama Ali Niranjan Meher Anju Wadhwa Suchi Dhrona Chandrashekhar Dasari Denis Beckford-Vera Yang Su Ryan Tang Li Zhang Jiang He David M. Wilson Rahul Aggarwal Henry F. VanBrocklin Youngho Seo Jonathan Chou Bin Liu Robert R. Flavell

View at Publisher

Ask AI

Bookmark

Share

Abstract

Figure S1: Immunohistochemical staining for PSMA expression on tissue section from patient-derived xenografts. Scale bar = 200 µm

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bidkar et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db6435875239de https://doi.org/10.1158/1078-0432.27030412.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S7 from Treatment of prostate cancer with CD46 targeted <sup>225</sup>Ac alpha particle radioimmunotherapy2024
2Figure S5 from Treatment of prostate cancer with CD46 targeted <sup>225</sup>Ac alpha particle radioimmunotherapy2024
3Figure S10 from Treatment of prostate cancer with CD46 targeted <sup>225</sup>Ac alpha particle radioimmunotherapy2024
4Supplementary Data 1 from Treatment of prostate cancer with CD46 targeted <sup>225</sup>Ac alpha particle radioimmunotherapy2024
5Supplementary Data 1 from Treatment of prostate cancer with CD46 targeted <sup>225</sup>Ac alpha particle radioimmunotherapy2024

More related papers

Figure S4 from Treatment of prostate cancer with CD46 targeted <sup>225</sup>Ac alpha particle radioimmunotherapy2024
Figure S6 from Treatment of prostate cancer with CD46 targeted <sup>225</sup>Ac alpha particle radioimmunotherapy2024
Figure S9 from Treatment of prostate cancer with CD46 targeted <sup>225</sup>Ac alpha particle radioimmunotherapy2024